ArticleAmerican journal of cancer research2024

LncRNA FEZF1-AS1 facilitates cisplatin resistance in non-small cell lung cancer through modulating the miR-32-5p-glutaminase axis.

Wei Lin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.